Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0YGNJ | ISIN: US36315X1019 | Ticker-Symbol: GXEA
Siehe auch GALAPAGOS NV
Frankfurt
31.03.25
08:04 Uhr
23,200 Euro
-0,200
-0,85 %
1-Jahres-Chart
GALAPAGOS NV ADR Chart 1 Jahr
5-Tage-Chart
GALAPAGOS NV ADR 5-Tage-Chart
RealtimeGeldBriefZeit
23,00023,40022:00

Aktuelle News zur GALAPAGOS NV ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrGALAPAGOS NV - 6-K, Report of foreign issuer4
DoGalapagos NV: Galapagos Publishes 2024 Annual Report and Announces Annual Shareholders' Meeting307Mechelen, Belgium; March 27, 2025, 21:01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) today publishes its annual report for the financial year 2024 and announces its Annual Shareholders'...
► Artikel lesen
DoGALAPAGOS NV - 20-F, Annual and transition report of foreign private issuers4
12.03.Euronext announces March 2025 annual review results of the BEL® Family indices: Montea NV will be added; Galapagos NV will be removed7
24.02.Galapagos NV: Galapagos to Present at Upcoming Investor Conferences472Mechelen, Belgium; February 24, 2025, 22:01 CET - Galapagos NVBarclays 27th Annual Global Healthcare ConferenceDate: Wednesday, March 12, 2025Location: Miami, FLCorporate Presentation: 11:00 - 11:25...
► Artikel lesen
24.02.GALAPAGOS NV - 6-K, Report of foreign issuer1
GALAPAGOS NV ADR Aktie jetzt für 0€ handeln
17.02.Galapagos NV: Galapagos receives transparency notification and 13D filing from Tang Capital450Mechelen, Belgium; February 17, 2025, 22:01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification and 13D filing from Tang Capital. Pursuant to...
► Artikel lesen
14.02.Galapagos downgraded at Morgan Stanley on new pipeline focus23
13.02.Galapagos projects 2026 pivotal trials for GLPG5101 following FDA clearance2
13.02.Galapagos drops one CD19 CAR-T to focus on 'flagship' program6
12.02.Galapagos GAAP EPS of €1.12, revenue of €275.6M9
12.02.Galapagos NV: Galapagos Reports Full Year 2024 Results and Provides Fourth Quarter Business Update625Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to deliver fresh, fit cells, in median seven days vein-to-vein Focusing...
► Artikel lesen
12.02.GALAPAGOS NV - 6-K, Report of foreign issuer1
11.02.Galapagos FY 2024 Earnings Preview33
23.01.Galapagos inks agreement with Catalent for experimental CAR-T therapy26
23.01.Galapagos downgraded by Barclays, PT cut to €2226
22.01.Catalent backs decentralised manufacture of Galapagos' CAR-T therapy14
21.01.Catalent to Support Galapagos' Decentralized CAR-T Therapy Trials4
17.01.Galapagos CEO Tells JPM Audience the Rationale for Planned Business Separation20
08.01.Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B15
Seite:  Weiter >>
58 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1